Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: A two-year follow-up study

Behaviour Research and Therapy

Volumn 51, Issue 12, 2013, Pages 830-839

  Gloster, Andrew T ^a,b   Hauke, Christina ^a   Höfler, Michael ^a   Einsle, Franziska ^a   Fydrich, Thomas ^c   Hamm, Alfons ^d   Sthröhle, Andreas ^e   Wittchen, Hans Ulrich ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Agoraphobia; CBT; Exposure; Long term follow up; Non responder; Panic

Indexed keywords

AGORAPHOBIA; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PANIC; PSYCHOTHERAPIST; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGORAPHOBIA; CBT; EXPOSURE; LONG TERM FOLLOW-UP; NON-RESPONDER; PANIC;

ADULT; AGORAPHOBIA; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84886817604     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2013.09.009     Document Type: Article

References (53)

1. Andersch S., Hetta J. A15-year follow-up study of patients with panic disorder. European Psychiatry: The Journal of the Association of European Psychiatrists 2003, 18(8):401-408.
2. Bandelow B. Panic and agoraphobia-scale (PAS) 1999, Hogrefe & Huber Publishers, Seattle.
3. Bandelow B., Baldwin D.S., Dolberg O.T., Andersen H.F., Stein D.J. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?. Journal of Clinical Psychiatry 2006, 67:1428-1434.
4. Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. Journal of American Medical Association 2000, 283(19):2529-2536.
5. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck depression inventory-II 1996, Psychological Corporation, San Antonio, TX.
6. de Beurs E., van Balkom A.J., Van Dyck R., Lange A. Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up. Acta Psychiatrica Scandinavica 1999, 99(1):59-67.
7. Bond F.W., Hayes S.C., Baer R.A., Carpenter K.M., Guenole N., Orcutt H.K., et al. Preliminary psychometric properties of the acceptance and action questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy 2011, 42:676-688. 10.1016/j.beth.2011.03.007.
8. Butler A.C., Chapman J.E., Forman E.M., Beck A.T. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clinical Psychology Review 2006, 26(1):17-31.
9. Cammin-Nowak S., Helbig-Lang S., Lang T., Gloster A.T., Fehm L., Gerlach A., et al. Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobia. Journal of Clinical Psychology 2013, 69:616-629.
10. Chambless D.L., Caputo G.C., Jasin S.E., Gracely E.J., Williams C. The mobility inventory for agoraphobia. Behaviour Research and Therapy 1985, 23(1):35-44.
11. Chambless D.L., Sharpless B.A., Rodriguez D., McCarthy K.S., Milrod B.L., Khalsa S., et al. Psychometric properties of the mobility inventory for agoraphobia: convergent, discriminant, and criterion related validity. Behavior Therapy 2011, 42:689-699.
12. Cottraux J., Note I.D., Cungi C., Legeron P., Heim F., Chneiweiss L., et al. Acontrolled-study of cognitive-behavior therapy with buspirone or placebo in panic disorder with agoraphobia. British Journal of Psychiatry 1995, 167:635-641.
13. Craske M., Brown T., Barlow D. Behavioral treatment of panic disorder: a two-year follow-up. Behavior Therapy 1991, 22:289-304.
14. Craske M.G., Kircanski K., Epstein A., Wittchen H.-U., Pine D.S., Lewis-Fernandez R., et al. Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V. Depression & Anxiety 2010, 27:3-112. DSM V Anxiety, OC Spectrum, Posttraumatic and Dissociative Disorder Work Group.
15. Craske M.G., Kircanski K., Zelikowsky M., Mystkowski J., Chowdhury N., Baker A. Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy 2008, 46:5-27.
16. Durham R.C., Chambers J.A., Power K.G., Sharp D.M., Macdonald R.R., Major K.A., et al. Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment 2005, 9(42):1-174.
17. Durham R.C., Higgins C., Chambers J.A., Swan J.S., Dow M.G.T. Long-term outcome of eight clinical trials of CBT for anxiety disorders: symptom profile of sustained recovery and treatment-resistant groups. Journal of Affective Disorders 2012, 136(3):875-881. 10.1016/J.Jad.2011.09.017.
18. Eifert G.H., Forsyth J.P. Acceptance & commitment therapy for anxiety disorders: A practitioner's treatment guide to using mindfulness, acceptance, and values-based behavior change strategies 2005, New Harbinger, Oakland, CA.
19. Emmrich, A., Wittchen, H.-U., Lueken, U., Einsle, F., Gloster, A. T., Helbig-Lang, S., etal. (2013). Exposure exercise completion in the treatment of panic disorder with agoraphobia: the role of depressive symptomatology (unpublished manuscript).
20. Essau C.A., Wittchen H.-U. An overview of the composite international diagnostic interview (CIDI). International Journal of Methods in Psychiatric Research 1993, 3:79-85.
21. Fava G.A., Rafanelli C., Grandi S., Conti S., Ruini C., Mangelli L., et al. Long-term outcome of panic disorder with agoraphobia treated by exposure. Psychological Medicine 2001, 31:891-898.
22. Fava G.A., Zielezny M., Savron G., Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. British Journal of Psychiatry 1995, 166:87-92.
23. Gloster A.T., Klotsche J., Chacker S., Hummel K., Hoyer J. Assessing psychological flexibility: what does it add above and beyond existing constructs?. Psychological Assessment 2011, 23:970-982.
24. Gloster A.T., Klotsche J., Gerlach A.L., Hamm A., Ströhle A., Gauggel S., et al. Timing matters: mediators of outcomes in cognitive behavioral therapy for panic disorder with agoraphobia depend on the stage of treatment. Journal of Consulting and Clinical Psychology 2013, 10.1037/a0034555.
25. Gloster A.T., Wittchen H.-U., Einsle F., Hoefler M., Lang T., Helbig-Lang S., et al. Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. European Archives of Psychiatry and Clinical Neuroscience 2009, 259:S155-S166.
26. Gloster A.T., Wittchen H.-U., Einsle F., Lang T., Helbig-Lang S., Fydrich T., et al. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in-situ in CBT. Journal of Consulting and Clinical Psychology 2011, 79:406-420. 10.1037/a0023584.
27. Guy W. ECDEU assessment manual for psychopharmacology 1976, U.S. Department of Health, Education, and Welfare, Rockville, MD.
28. Hautzinger M., Keller F., Kühner C. Beck depression Inventar II (BDI 2) 2006, Harcourt Test Service, Frankfurt.
29. Heldt E., Blaya C., Kipper L., Salum G.A., Otto M.W., Manfro G.G. Defense mechanisms after brief cognitive-behavior group therapy for panic disorder. Journal of Nervous and Mental Disease 2007, 195:540-543.
30. Jacobson N.S., Truax P. Clinical-significance - a statistical approach to defining meaningful change in psychotherapy-research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
31. Lachner G., Wittchen H.-U., Perkonigg A., Holly A., Schuster P., Wunderlich U., et al. Structure, content and reliability of the Munich-composite international diagnostic interview (M-CIDI) substance use sections. European Addiction Research 1988, 4:28-41.
32. Lang T., Helbig-Lang S., Westphal D., Gloster A.T., Wittchen H.-U. Expositionsbasierte Therapie der Panikstörung mit Agoraphobie: Ein Behandlungsmanual 2012, Hogrefe, Göttingen.
33. Marchand A., Roberge P., Primiano S., Germain V. Arandomized, controlled clinical trail of standard, group and brief cognitive-behavioral therapy for panic disorder with agoraphobia: a two-year follow-up. Journal of Anxiety Disorders 2009, 23:1139-1147.
34. Pollack M., Mangano R., Entsuah R., Tzanis E., Simon N.M. Arandomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology 2007, 194:233-242.
35. Pollack M.H., Otto M.W., Roy-Byrne P.P., Coplan J.D., Rothbaum B.O., Simon N.M., et al. Novel treatment approaches for refractory anxiety disorders. Depression and Anxiety 2008, 25:467-476.
36. Powers M.B., Smits J.A.J., Telch M.J. Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology 2004, 72:448-454. 10.1037/0022-006X.72.3.448.
37. Reed V., Gander F., Pfister H., Steiger A., Sonntag H., Trenkwalder C., et al. To what degree does the composite international diagnostic interview (CIDI) correctly identify DSM-IV disorders? Testing validity issues in a clinical sample. International Journal of Methods in Psychiatric Research 1998, 7:142-155. 10.1002/mpr.44.
38. Reif A., Richter J., Straube B., Höfler M., Lueken U., Gloster A.T., et al. MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Molecular Psychiatry 2013, 10.1038/mp.2012.172.
39. Reiss S., Peterson R.P., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behavior Research and Therapy 1986, 24:1-8.
40. Robins J.N., Wing J., Wittchen H.-U., Helzer J.E., Babor T.F., Burke J., et al. The composite international diagnostic interview: an epidemiologic instrument suitable for the use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry 1988, 45:1069-1077.
41. Royall R. Model robust inference using maximum likelihood estimators. International Statistical Review. 1986, 54:221-226.
42. Sánchez-Meca J., Rosa-Alcázar A.I., Marín-Martínez F., Gómez-Conesa A. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clinical Psychology Review 2010, 30:37-50.
43. Schlaepfer T.E., Agren H., Monteleone P., Gasto C., Pitchot W., Rouillon F., et al. The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology 2012, 1-16.
44. Shear M.K., Vander Bilt J., Rucci P., Endicott J., Lydiard B., Otto M.W., et al. Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A). Depression and Anxiety 2001, 13(4):166-178.
45. Skrondal A., Rabe-Hesketh S. Generalized latent variable modeling 2004, Chapman & Hall.
46. Smits J.A.J., Powers M.B., Cho Y.R., Telch M.J. Mechanism of change in cognitive-behavioral treatment of panic dis-order: evidence for the fear of fear meditational hypothesis. Journal of Consulting and Clinical Psychology 2004, 72:646-652. 10.1037/0022-006X.72.4.646.
47. StataCorp Stata statistical software, release 12.1 2012, Stata Corporation, College Station, TX.
48. Williams S.L., Falbo J. Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability. Behaviour Research and Therapy 1996, 34(3):253-264.
49. Wittchen H.-U. Reliability and validity studies of the WHO-composite international diagnostic interview (CIDI): a critical review. Journal of Psychiatric Research 1994, 28:57-84.
50. Wittchen H.-U., Gloster A.T., Beesdo-Baum K., Fava G.A., Craske M.G. Agoraphobia: a review of the diagnostic classificatory position and criteria. Depression & Anxiety 2010, 27:113-133.
51. Wittchen H.-U., Nocon A., Beesdo K., Pine D.S., Hofler M., Lieb R., et al. Agoraphobia and panic: prospective-longitudinal relations suggest a rethinking of diagnostic concepts. Psychotherapy and Psychosomatics 2008, 77:147-157. 10.1159/000116608.
52. Wittchen H.-U., Pfister H. DIA-X Interview. Instruktionsmanualzur Durchführung von DIA-X-Interviews 1997, Swets & Zeitlinger, Frankfurt.
53. Wood A.M., Hillsdon M., Carpenter J. Comparison of imputation and modeling methods in the analysis of a physical activity trial with missing outcomes. International Journal of Epidemiology 2005, 34:89-99.